Fast Track Pathway May Be ‘Poor Man’s Breakthrough’ But It Works

 
• By Bridget Silverman

Most requests for the FDA’s less-heralded expedited review designation are based on Phase II or earlier data, and have a greater chance of success than requests for breakthrough designation.

train fast run on railway track in sunny day
The US FDA has approved nearly 70% of fast track requests. • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards